863
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Decreased neurokinin B as a risk factor of functional hypothalamic amenorrhea

, , &
Article: 2216313 | Received 27 Dec 2022, Accepted 15 May 2023, Published online: 24 May 2023

References

  • Topaloglu AK, Reimann F, Guclu M, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the Central control of reproduction. Nat Genet. 2009;41(3):1–5.
  • Almeida TA, Rojo J, Nieto PM, et al. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem. 2004;11(15):2045–2081.
  • Chawla MK, Gutierrez GM, Young WS, et al. Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain. J Comp Neurol. 1997;384(3):429–442.
  • Navarro VM, Gottsch ML, Chavkin C, et al. Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse. J Neurosci. 2009;29(38):11859–11866.
  • Wakabayashi Y, Nakada T, Murata K, et al. Neurokinin B and dynorphin a in kisspeptin neurons of the arcuate nucleus participate in generation of periodic oscillation of neural activity driving pulsatile Gonadotropin-Releasing hormone secretion in the goat. J Neurosci. 2010;30(8):3124–3132.
  • Ramaswamy S, Seminara SB, Ali B, et al. Neurokinin B stimulates GnRH release in the male monkey (Macaca mulatta) and is colocalized with kisspeptin in the arcuate nucleus. Endocrinology. 2010;151(9):4494–4503.
  • Foradori CD, Amstalden M, Goodman RL, et al. Colocalisation of dynorphin a and neurokinin B immunoreactivity in the arcuate nucleus and median eminence of the sheep. J Neuroendocrinol. 2006;18(7):534–541.
  • Szeliga A, Czyzyk A, Podfigurna A, et al. The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications. Gynecol Endocrinol. 2018;34(11):913–919.
  • Szeliga A, Rudnicka E, Maciejewska-Jeske M, et al. Neuroendocrine determinants of polycystic ovary syndrome. Int J Environ Res Public Health. 2022;19(5):3089.
  • Cheng G, Coolen LM, Padmanabhan V, et al. The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep. Endocrinology. 2010;151(1):301–311.
  • Moore AM, Coolen LM, Lehman MN. Kisspeptin/neurokinin B/dynorphin (KNDy) cells as integrators of diverse internal and external cues: evidence from viral-based monosynaptic tract-tracing in mice. Sci Rep. 2019;9(1):14768.
  • Gianetti E, Tusset C, Noel SD, et al. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab. 2010;95(6):2857–2867.
  • Young J, Bouligand J, Francou B, et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab. 2010;95(5):2287–2295.
  • Tusset C, Noel SD, Trarbach EB, et al. Mutational analysis of TAC3 and TACR3 genes in patients with idiopathic Central pubertal disorders. Arq Bras Endocrinol Metabol. 2012;56(9):646–652. http://www.ncbi.nlm.nih.gov/pubmed/23329188.
  • Meczekalski B, Niwczyk O, Bala G, et al. Stress, kisspeptin, and functional hypothalamic amenorrhea. Curr Opin Pharmacol. 2022;67:102288.
  • Rance NE, Krajewski SJ, Smith MA, et al. Neurokinin B and the hypothalamic regulation of reproduction. Brain Res. 2010;1364:116–128.
  • Szeliga A, Podfigurna A, Bala G, et al. Kisspeptin and neurokinin B analogs use in gynecological endocrinology: where do we stand? J Endocrinol Invest. 2020;43(5):555–561.
  • Podfigurna A, Szeliga A, Meczekalski B. Serum kisspeptin and corticotropin-releasing hormone levels in patients with functional hypothalamic amenorrhea. Gynecol Reprod Endocrinol Metab. 2020;1(1):37–42.
  • Podfigurna A, Czyżyk A, Męczekalski B. Serum kisspeptin levels in patients with anorexia nervosa. Pol Merkur Lekarski. 2018;45(265):24–27. http://www.ncbi.nlm.nih.gov/pubmed/30058623.
  • Bacopoulou F, Lambrou GI, Rodanaki M-E, et al. Serum kisspeptin concentrations are negatively correlated with body mass index in adolescents with anorexia nervosa and amenorrhea. Hormones (Athens). 2017;16(1):33–41.
  • Hofmann T, Elbelt U, Haas V, et al. Plasma kisspeptin and ghrelin levels are independently correlated with physical activity in patients with anorexia nervosa. Appetite. 2017;108:141–150.
  • Rafique N, Latif R. Serum kisspeptin levels in normal and overweight saudi females and its relation with anthropometric indices. Ann Saudi Med. 2015;35(2):157–160.
  • Rashad NM, Al-Sayed RM, Yousef MS, et al. Kisspeptin and body weight homeostasis in relation to phenotypic features of polycystic ovary syndrome; metabolic regulation of reproduction. Diabetes Metab Syndr. 2019;13(3):2086–2092.
  • Latif R, Rafique N. Serum kisspeptin levels across different phases of the menstrual cycle and their correlation with serum oestradiol. Neth J Med. 2015;73(4):175–178. http://www.ncbi.nlm.nih.gov/pubmed/25968289.
  • Katagiri F, Kotani M, Hirai T, et al. The relationship between circulating kisspeptin and sexual hormones levels in healthy females. Biochem Biophys Res Commun. 2015;458(3):663–666.
  • Andreozzi F, Chiara Mannino G, Mancuso E, et al. Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals. PloS one. 2017;12(16):e0179834.
  • Panidis D, Rousso D, Koliakos G, et al. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil Steril. 2006;85(6):1778–1783.